Realta Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Realta Investment Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.22K	Sell	61 -3,303	-98%	-$357K	﹤0.01%	327
2026 Q1	$349K	Buy	3,364 +3,289	+4,385%	+$347K	0.12%	146
2025 Q4	$7.84K	Buy	+75	New	+$7.54K	﹤0.01%	300
2023 Q3	–	Sell	-125	Closed	-$9.45K	–	806
2023 Q2	$9.45K	Buy	+125	New	+$9.54K	﹤0.01%	729
2023 Q1	–	Sell	-125	Closed	-$9.82K	–	704
2022 Q4	$9.82K	Hold	125	–	–	﹤0.01%	719
2022 Q3	$9K	Buy	+125	New	+$9.32K	﹤0.01%	707
2020 Q1	–	Sell	-125	Closed	-$8K	–	1090
2019 Q4	$8K	Hold	125	–	–	﹤0.01%	1207
2019 Q3	$7K	Hold	125	–	–	﹤0.01%	1230
2019 Q2	$8K	Hold	125	–	–	﹤0.01%	1218
2019 Q1	$8K	Buy	+125	New	+$8.21K	﹤0.01%	970

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Realta Investment Advisors's PJP Position: Q2 2026 in Review

Realta Investment Advisors reduced its Invesco Pharmaceuticals ETF (PJP) stake by 98% in Q2 2026, selling an estimated $357K and leaving 61 shares worth $7.22K. The position accounts for ﹤0.01% of the portfolio, ranked #327.

Realta Investment Advisors first reported a position in PJP in Q1 2019 and has held it in 10 quarters since. The position peaked at $349K in Q1 2026. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Realta Investment Advisors held 61 shares of Invesco Pharmaceuticals ETF worth $7.22K as of Q2 2026.
Realta Investment Advisors sold 3,303 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $357K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Realta Investment Advisors's portfolio in Q2 2026, its #327 holding.
Realta Investment Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2019 and has held it in 10 quarters since.
Realta Investment Advisors's Invesco Pharmaceuticals ETF position peaked at $349K in Q1 2026.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Realta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.